Texas Stem Cell Clinics Face Scrutiny Over Efficacy Claims

Austin has emerged as a leading market for regenerative orthobiologic treatments, with local clinics offering mesenchymal stem cell injections to athletes, health‑conscious adults and older patients seeking alternatives to surgery. The therapy involves harvesting a patient’s own bone‑marrow or fat‑derived stem cells, concentrating them and injecting them into damaged tissue to modulate inflammation and support repair. While proponents describe it as regenerative rather than merely symptomatic, clinical evidence remains limited.

In North Houston, Houston Regenerative Medicine warned that published research does not establish how long any benefit from knee stem‑cell therapy lasts. The clinic noted that the U.S. Food and Drug Administration has not approved any stem‑cell product for orthopedic conditions and that most orthobiologic procedures are performed outside FDA approval. Systematic reviews of randomized trials have found little to no pain relief or functional improvement compared with placebo, though safety profiles appear favorable. The clinic’s founder, Joel Cherdack, emphasized that patients should be told the research does not support definitive duration or cartilage‑regeneration claims.